Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2007-12-25
2007-12-25
Campbell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C530S388260, C530S388300, C424S184100, C435S320100, C435S002000, C435S007800
Reexamination Certificate
active
11116937
ABSTRACT:
Monoclonal antibodies to thymidine kinase 1 are disclosed which are useful in methods of detecting, diagnosing, and treating viral infection.
REFERENCES:
patent: 4317877 (1982-03-01), Balis et al.
patent: 4474893 (1984-10-01), Reading
patent: 4722899 (1988-02-01), Hamaoka et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5476996 (1995-12-01), Wilson et al.
patent: 5514548 (1996-05-01), Krebber et al.
patent: 5698409 (1997-12-01), O'neill
patent: 5869045 (1999-02-01), Hellstrom et al.
patent: 6083707 (2000-07-01), Eriksson et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6372217 (2002-04-01), Uckun
patent: 2006/0039914 (2006-02-01), Lallatin et al.
patent: 0042482 (1981-12-01), None
patent: 0255431 (1991-10-01), None
patent: 0454478 (1991-10-01), None
patent: 9306213 (1993-04-01), None
patent: 9708320 (1997-03-01), None
Groschel et al. Infection 2000, vol. 28, No. 4, pp. 209-213.
U.S. Appl. No. 60/567,344 filed Apr. 30, 2004, Lallatin.
Balzarini et al. (1982) “Role of Thymidine Kinase in the Inhibitory Activity of 5-Substituted-2'Deoxyuridines on the Growth of Human and Murine Tumor Cell Lines,” Biochem. Pharmacol. 31(6):1089-1095.
Baron et al. (1990) “A Rapid Two-Step Purification of Rat Liver Fetal Thymidine Kinase,” Preparative Biochem. 20 (3-4):241-256.
Boivin et al. (2002) “Intranasal Herpes Simplex Virus Type 2 Inoculation Causes a Profound Thymidine Kinase Dependent Cerebral Inflammatory Response in the Mouse Hindbrain,” Eur. J. Neurosci. 16(1):29-43.
Bradshaw, H.D. Jr. (1983) “Molecular Cloning and Cell-Specific Regulation of a Functional Human Thymidine Kinase Gene,” Proc. Natl. Acad. Sci. USA 80:5588-5591.
Bronzert et al. (1981) “Purification and Properties of the Estrogen-Responsive Cytoplasmic Thymidine Kinase from Human Breast Cancer,” Cancer Res. 41:604-610.
Daugherty et al. (1991) “Polymerase Chain Reaction Facilitates the Cloning, CDR-Grafting, and Rapid Expression of a Murine Monoclonal Antibody Directed Against the CD18 Component of Leukocyte Integrins,” Nuc. Acids Res. 19 (9):2471-2476.
Ellims et al. (1982) “Human Thymidine Kinase: Purification and Some Properties of the TK1 Isoenzyme from Placenta,” Mol. Cell. Biochem. 45:113-116.
Flemington (1987) “Sequence, Structure and Promoter Characterization of the Human Thymidine Gene,” Gene 52:267-277.
Gan et al. (1983) “Human Thymidine Kinase,” J. Biol. Chem. 258:7000-7004.
Goding et al. (1980) “Antibody Production by Hybridomas,” J. Immunol. Methods 39:285-308.
Gronowitz et al. (1984) “Application of an In Vitro Assay for Serum Thymidine Kinase: Results on Viral Disease and Malignancies in Humans,” Int. J. Cancer 33:5-12.
Habteyesus et al. (1991) “Deoxynucleside Phosphorylating Enzymes in Monkey and Human Tissues Show Great Similarities, While Mouse Deoxycytidine Kinase has a Different Substrate Specificity,” Biochem. Pharmacol. 42(9):P1829-P1836.
Hannigan et al. (1993) “Thymidine Kinase: The Enzymes and Their Clinical Usefulness,” Cancer Biother. 8(3):187-197.
Hengstschlager et al. (1994) “Different Regulation of Thymidine Kinase During the Cell Cycle of Normal Versus DNA Tumor Virus-Transformed Cells,” J. Biol. Chem. 269:13836-13842.
Hengstschlager et al. (1994) “A Common Regulation of Genes Encoding Enzymes of the Deoxynucleotide Metabolism is Lost After Neoplastic Transformation,” Cell Growth Differ. 5(12):1389-1394.
Hengstschlager et al. (1993) “Cytofluorometric Assay for the Determination of Thymidine Uptake and Phosphorylation in Living Cells,” Cytometry 14:39-445.
Jansson et al. (1992) “Mammalian Thymidine Kinase 2, Direct Photoaffinity Labeling with [32P]dTTP of the Enzyme from Spleen, Liver, Heart and Brain,” Eur. J. Biochem. 206(2):485-490.
Kohler et al. (1976) “Derivation of Specific Antibody-Producing Tissue Culture and Tumor Lines by Cell Fusion,” J. Immunol. 6:511-519.
Lau et al. (1994) “Direct Isolation of the Functional Human Thymidine Kinase Gene W/A Cosmid Shuttle Vector,” Proc. Natl. Acad. Sci. USA 81:414-418.
May et al. (1991) “Intracellular Routing Rather than Cross-Linking or Rate of Internalization Determines the Potency of Immunotoxins Directed Against Different Epitopes of sigD on Murine B Cells,” Cell Immunol. 135:490-500.
McKenna et al. (1988) “Thymidine Kinase Activities in Mononuclear Leucocytes and Serum from Breast Cancer Patients,” Br. J. Cancer 57:619-622.
Munch-Peterson et al. (1990) “Thymidine Kinase in Human Leukemia—Expression of Three Isoenzyme Variants in Six Patients with Chronic Myelocytic Leukemia,” Leuk. Res. 14:39-45.
Munch-Peterson et al. (1991) “Diverging Substrate Specificity of Pure Human Thymidine Kinases 1 and 2 Against antiviral Dideoxynucleosides,” J. Biol. Chem. 266:9032-9038.
Munch Peterson et al. (1993) “Reversible ATP-Dependent Transition Between Two Forms of Human Cytosolic Thymidine Kinase With Different Enzymatic Properties,” J. Biol. Chem. 268(21):15621-15625.
Oldham et al. (1993) “Whats the Score,” Cancer Biother. 8(3):187-188.
O'Neill et al. (1992) “Can Thymidine Kinase Levels in Breast Tumors Predict Disease Recurrence,” J. Nat. Cancer Inst. 84(23):1825-1828.
O'Neill et al. (1987) “Elevated Serum and Mononuclear Leukocyte Thymidine Kinase Activities in Patients with Cancer,” Irish Med. J. 80(9):264-265.
Seaver et al. (1994) “Monoclonal Antibodies in Industry: More Difficult Than Originally Thought,” Genetic Eng. News pp. 10,21.
Sherley et al. (1988) “Human Cytosolic Thymidine Kinase,” J. Biol. Chem. 263:375-391.
Tamiya et al. (1989) “Co-Purification of Thymidylate Kinase and Cytosolic Thymidine Kinase from Human Term Placenta by Affinity Chromatography,” Biochem. Biophys. Acta 995:28-35.
Topolcan et al. (2005) “Changes of Thymidine Kinase (TK) During Adjuvant and Palliative Chemotherapy,” Anticancer Res. 25:1831-1834.
Willingham et al. (1987) “Pseudomonas Exotoxin Coupled to a Monoclonal Antibody Against Ovarian Cancer Inhibits the Growth of Human Ovarian Cancer Cells in a Mouse Model,” Proc.Natl. Acad. Sci. USA 84:2474-2478.
Lallatin Nathaniel
O'Neill Kim L.
Brigham Young University
Campbell Bruce R.
Greenlee Winner and Sullivan P.C.
Li Bao Qun
LandOfFree
Anti-viral activity of an anti-thymidine kinase monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-viral activity of an anti-thymidine kinase monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-viral activity of an anti-thymidine kinase monoclonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850956